Trial
NCT01849276
Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
—
Condition
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention
metformin hydrochloride
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-31